Filing Details
- Accession Number:
- 0001214659-22-015200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-21 21:21:33
- Reporting Period:
- 2022-12-19
- Accepted Time:
- 2022-12-21 21:21:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579824 | M Charles Baum | C/O Mirati Therapeutics Inc. 3545 Cray Court San Diego CA 92121 | President,Founder,Head Of R&D | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-19 | 53,618 | $0.00 | 181,517 | No | 4 | A | Direct | |
Common Stock | Disposition | 2022-12-21 | 9,092 | $40.42 | 172,425 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Award of Performance Stock Units ("PSUs"). 1/3 of the PSUs have vested on December 19, 2022 (one week after the "Achievement Date" of December 12, 2022). 1/3 of the remaining shares will vest on the one year anniversary of the Achievement Date and the remaining 1/3 will vest on the two year anniversary of the Achievement Date, subject to Mr. Baum's continuous service.
- Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1.